Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

Johnson & Johnson Pops on Top- and Bottom-Line Beat, Boost to Full-Year Outlook

Summary by sherwood.news
The drugmaker’s “grind it out” year is paying off, with sales jumping even as its blockbuster treatment faces more competition....

3 Articles

sherwood.newssherwood.news
Lean Left

Johnson & Johnson pops on top- and bottom-line beat, boost to full-year outlook

The drugmaker’s “grind it out” year is paying off, with sales jumping even as its blockbuster treatment faces more competition....

Read Full Article
sta.sista.si

Sta: Johnson & Johnson Exceeds Expectations with Quarterly Profit and Revenue

American pharmaceutical giant Johnson & Johnson reported lower profit in the second quarter of this year than in the same quarter last year. It amounted to $2.77 per share, which is 1.8 percent less than last year, but still more than Wall Street analysts expected, business television channel CNBC reported.

Read Full Article
endpoints.newsendpoints.news

Updated: J&J's Stelara faces continued biosimilar competition, with Q2 revenue falling 43%

Johnson & Johnson said revenue for its megablockbuster Stelara continued to decline in the face of emerging biosimilar competition. The company said Tuesday that global sales of Stelara were down 42 ...

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

endpoints.news broke the news in on Wednesday, July 16, 2025.
Sources are mostly out of (0)

Similar News Topics

Johnson & Johnson icon

Johnson & Johnson

News
For You
SearchBlindspotLocal